Literature DB >> 3333141

Pathological features of Kawasaki disease (mucocutaneous lymph node syndrome).

B H Landing1, E J Larson.   

Abstract

Kawasaki disease (mucocutaneous lymph node syndrome) (MCLS) is an apparently infectious disease, an etiological agent of which has not been established, with peak age incidence at about 1 year, but with progressively fewer cases occurring into the fourth decade. Early clinical features include fever, rash, conjunctival injection, dry reddened lips, oropharyngeal reddening, enlarged cervical nodes, and swelling and redness of hands and feet. Peeling of skin of fingers and toes, arthralgia, and marked thrombocytosis are frequent 1-2 weeks after onset. Myocarditis, cardiac valvulitis, and lymphocytic or mixed interstitial infiltration of pancreas, renal, splenic, and hepatic hilar regions are seen in the early phase, but arteritis, typically of extraparenchymal arteries, is the most important aspect of MCLS, hence the term infantile periarteritis nodosa, formerly applied to fatal cases of MCLS. Thrombosis of coronary artery aneurysms is the most common cause of death (rate about 0.5%). The peak time of death is 3-4 weeks from onset, but death from coronary occlusion has been seen as late as 14 years after the acute phase. Aneurysmal rupture with hemopericardium or retroperitoneal hemorrhage is rare, as are late brachial, iliac, or other arterial aneurysms. Pathological features of MCLS in the early and later stages are described and illustrated, and the epidemiologic, etiologic, forensic, and other aspects of the disease are discussed.

Entities:  

Mesh:

Year:  1987        PMID: 3333141

Source DB:  PubMed          Journal:  Am J Cardiovasc Pathol        ISSN: 0887-8005


  15 in total

1.  Th1 and Th2 cytokine production is suppressed at the level of transcriptional regulation in Kawasaki disease.

Authors:  J Kimura; H Takada; A Nomura; T Ohno; Y Mizuno; M Saito; K Kusuhara; T Hara
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

2.  Clinical implications of a new model of Kawasaki disease arteriopathy.

Authors:  Anne H Rowley; Jan M Orenstein
Journal:  Pediatr Cardiol       Date:  2013-02-23       Impact factor: 1.655

3.  Discordance between dipyridamole stress Tc-99m sestamibi SPECT and coronary angiography in patients with Kawasaki disease.

Authors:  Yun-Ching Fu; Chia-Hung Kao; Betau Hwang; Sheng-Ling Jan; Ching-Shiang Chi
Journal:  J Nucl Cardiol       Date:  2002 Jan-Feb       Impact factor: 5.952

4.  Increased frequency of immunoglobulin (Ig)A-secreting cells following Toll-like receptor (TLR)-9 engagement in patients with Kawasaki disease.

Authors:  L Giordani; M G Quaranta; A Marchesi; E Straface; D Pietraforte; A Villani; W Malorni; D Del Principe; M Viora
Journal:  Clin Exp Immunol       Date:  2010-12-22       Impact factor: 4.330

5.  Discordance between thallium-201 scintigraphy and coronary angiography in patients with Kawasaki disease: myocardial ischemia with normal coronary angiogram.

Authors:  M Fukazawa; J Fukushige; T Takeuchi; H Narabayashi; H Igarashi; T Hijii; K Ueda; Y Kuwabara; M Otsuka; Y Ichiya
Journal:  Pediatr Cardiol       Date:  1993-03       Impact factor: 1.655

6.  Kawasaki disease as a systemic vasculitis in childhood.

Authors:  Kei Takahashi; Toshiaki Oharaseki; Yuki Yokouchi; Nobuyuki Hiruta; Shiro Naoe
Journal:  Ann Vasc Dis       Date:  2010-12-02

7.  Kawasaki disease: basic and pathological findings.

Authors:  Kei Takahashi; Toshiaki Oharaseki; Yuki Yokouchi; Shiro Naoe; Tsutomu Saji
Journal:  Clin Exp Nephrol       Date:  2012-11-28       Impact factor: 2.801

8.  Discordance between dipyridamole stress technetium-99m tetrofosmin single photon emission computed tomography and coronary angiography in patients with Kawasaki disease.

Authors:  Yun-Ching Fu; Yu-Chien Shiau; Shih-Chuan Tsai; Albert Kao; Betau Hwang; Ching-Shiang Chi
Journal:  Int J Cardiovasc Imaging       Date:  2002-10       Impact factor: 2.357

9.  Allograft Inflammatory Factor-1 Links T-Cell Activation, Interferon Response, and Macrophage Activation in Chronic Kawasaki Disease Arteritis.

Authors:  Anne H Rowley; Susan C Baker; Kwang-Youn A Kim; Stanford T Shulman; Amy Yang; David Arrollo; Matthew DeBerge; Shuling Han; Nicholas E S Sibinga; Adam J Pink; Edward B Thorp
Journal:  J Pediatric Infect Dis Soc       Date:  2017-09-01       Impact factor: 3.164

10.  Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study.

Authors:  Jan Marc Orenstein; Stanford T Shulman; Linda M Fox; Susan C Baker; Masato Takahashi; Tricia R Bhatti; Pierre A Russo; Gary W Mierau; Jean Pierre de Chadarévian; Elizabeth J Perlman; Cynthia Trevenen; Alexandre T Rotta; Mitra B Kalelkar; Anne H Rowley
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.